ExodusPoint Capital Management LP Sells 14,026 Shares of Maximus, Inc. (NYSE:MMS)

ExodusPoint Capital Management LP lowered its holdings in Maximus, Inc. (NYSE:MMS - Free Report) by 58.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,084 shares of the health services provider's stock after selling 14,026 shares during the period. ExodusPoint Capital Management LP's holdings in Maximus were worth $753,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in MMS. World Investment Advisors boosted its position in shares of Maximus by 41.6% in the 4th quarter. World Investment Advisors now owns 7,488 shares of the health services provider's stock valued at $559,000 after purchasing an additional 2,199 shares during the period. Bryce Point Capital LLC purchased a new stake in Maximus during the fourth quarter valued at about $1,639,000. Trexquant Investment LP boosted its holdings in shares of Maximus by 19.8% in the fourth quarter. Trexquant Investment LP now owns 176,003 shares of the health services provider's stock worth $13,139,000 after buying an additional 29,073 shares during the period. Headlands Technologies LLC purchased a new position in shares of Maximus in the fourth quarter worth approximately $290,000. Finally, Franklin Resources Inc. increased its position in shares of Maximus by 21.8% in the fourth quarter. Franklin Resources Inc. now owns 6,176 shares of the health services provider's stock worth $461,000 after acquiring an additional 1,104 shares in the last quarter. 97.21% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

MMS has been the subject of a number of recent analyst reports. StockNews.com lowered shares of Maximus from a "buy" rating to a "hold" rating in a research note on Friday, February 14th. Raymond James raised Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 target price for the company in a research report on Thursday, January 2nd.

Remove Ads

Insider Buying and Selling at Maximus

In other Maximus news, Director Jan Madsen sold 2,439 shares of the business's stock in a transaction that occurred on Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total value of $165,144.69. Following the completion of the sale, the director now directly owns 18,097 shares of the company's stock, valued at $1,225,347.87. The trade was a 11.88 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Ilene R. Baylinson sold 14,500 shares of the firm's stock in a transaction on Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total transaction of $988,030.00. Following the transaction, the insider now owns 2,512 shares in the company, valued at $171,167.68. This represents a 85.23 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.60% of the company's stock.

Maximus Stock Down 1.4 %

Shares of MMS traded down $0.95 during trading hours on Wednesday, reaching $67.14. The company's stock had a trading volume of 132,300 shares, compared to its average volume of 677,204. The company has a 50 day moving average of $67.71 and a two-hundred day moving average of $75.82. The company has a quick ratio of 1.72, a current ratio of 1.72 and a debt-to-equity ratio of 0.82. The firm has a market cap of $3.80 billion, a price-to-earnings ratio of 14.44 and a beta of 0.68. Maximus, Inc. has a 1-year low of $63.77 and a 1-year high of $93.97.

Maximus (NYSE:MMS - Get Free Report) last released its quarterly earnings data on Thursday, February 6th. The health services provider reported $1.61 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. As a group, research analysts predict that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

Maximus Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Saturday, May 31st. Investors of record on Thursday, May 15th will be given a dividend of $0.30 per share. The ex-dividend date is Thursday, May 15th. This represents a $1.20 dividend on an annualized basis and a yield of 1.79%. Maximus's payout ratio is 25.81%.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.